Verition Fund Management LLC Amgen Inc Call Options Transaction History

Verition Fund Management LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $394,125 - $478,965	1,500 New	1,500 $468,000
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $91,612 - $116,404	-400 Reduced 2.7%	14,400 $3.78 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $3.32 Million - $3.75 Million	14,800 New	14,800 $3.34 Million
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $1.62 Million - $1.8 Million	7,400 Added 62.71%	19,200 $4.64 Million
Q4 2021 May 03, 2022	BUY	$198.88 - $227.6 $2.35 Million - $2.69 Million	11,800 New	11,800 $2.66 Million

3,122

410M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.